Dr Rebecca Winter
Deputy Head, Justice Health
Working groups
Background
Rebecca Winter has over 15 years of experience in public health research. Primarily, she has worked on studies relating to risk behaviours and risk groups relating to communicable disease transmission, with a particular interest in drug user and justice-involved populations.
Rebecca completed her doctoral studies on injecting drug-related harms among prisoners and ex-prisoners in 2016.
Qualifications
- 2017: PhD, Monash University, Australia
- 2010: MPH, Latrobe University, Australia
- 2002: BA, Latrobe University, Australia
Appointments
- Burnet Fellow; Honorary Research Fellow, St Vincent's Hospital Melbourne
- Adjunct Research Fellow, School of Public Health and Preventive Medicine, Monash University
Awards
- 2016: Burnet Institute Travel Award
- 2013: ICAAP (International Conference on AIDS in Asia and the Pacific) student scholarship, Bangkok, Thailand
- 2012: NIDA Conference Scholarship, Academic and Health Policy Conference on Correctional Health, Atlanta, GA, USA
- 2010: National Health and Medical Research Council (NHMRC) PhD Scholarship, Dora Lush Public Health Scholarship
Positions
- 2022: Deputy Head Justice Health Group
- 2022: Research Fellow, Burnet Institute
- 2020: Senior Research Officer, Burnet Institute
- 2016: Research Officer, Burnet Institute
- 2011-2016: PhD candidate, Monash University and Burnet Institute
- 2005-2010: Research Assistant, Burnet Institute
Burnet publications
View 41 moreExploring sexual and reproductive health and rights among women who use illegal drugs in Australia
Sophia Schroeder et al
The determinants of health and health status of individuals in police custody in Australia: A scoping review
PLoS ONE
Joshua F. Ginnane et al
The Hepatitis C Cascade of Care for Opioid Agonist Therapy Recipients in Australia
Clinical Infectious Diseases
S. Griffin et al
Reports and other work
-
Technical review of hepatitis C health promotion resources.
The hepatitis C virus impacts approximately 200,000 Australians, according to the National Centre in HIV Epidemiology and Clinical Research (NCHECR) in 2010. Presently, there is no vaccine available to prevent transmission of the virus. In New South Wales alone, there were 3,950 new diagnoses of hepatitis C infection in 2009, as reported by the NCHECR.
Technical review of hepatitis C health promotion resources. -
Exploring sexual and reproductive health and rights among women who use illegal drugs in Australia
Burnet conducted an exploratory qualitative study in 2023. The aim was to start addressing the gap in evidence on the sexual and reproductive health needs of women who use illegal drugs.
Exploring sexual and reproductive health and rights among women who use illegal drugs in Australia
Current projects
View 3 moreSubstance use support for women moving in and out of prison (SUSTain)
We’re delivering alcohol and other drugs transitional care for women leaving prison – codesigned with those who know it best.
Unlocking health: using linked administrative data to improve health outcomes for people incarcerated in Victoria
In this project we aim to establish a system for monitoring health and health service use among people leaving prison in Victoria.
Achieving the final phases of hepatitis C elimination using innovative models of care
We're identifying innovative models of care so that no-one misses out on HCV care in Australia and globally.
Past projects
View 3 more
Eliminate C (EC) Victoria partnership
A partnership aimed at increasing hepatitis C treatment uptake among people who inject drugs (PWID) using nurse-led models of care in community and prison settings.
Co-EC Study: Eliminating hepatitis C/HIV coinfection
The co-EC study aimed to eliminate hepatitis C/HIV coinfection among gay and bisexual men through scale up treatment of hepatitis C in primary care and hospital settings.
The B-VAX Project: Hep B vaccinations for people who inject drugs
People who inject drugs (PWID) are at substantial risk for the transmission of hepatitis viruses. Despite the availability of an effective HBV vaccine, a considerable proportion of PWID in Australia remain unvaccinated.